Butler, Javed
Petrie, Mark C.
Bains, Marc
Bawtinheimer, Tracy
Code, Jillianne
Levitch, Teresa
Malvolti, Elmas
Monteleone, Pasquale
Stevens, Petrina
Vafeiadou, Jenny
Lam, Carolyn S. P.
Article History
Received: 14 June 2022
Accepted: 25 January 2023
First Online: 13 April 2023
Declarations
:
: Not applicable.
: Teresa Levitch, Javed Butler, and Petrina Stevens consented to their appearance in the video and podcast. Written informed consent for the publication of their image/voice was obtained from Teresa Levitch, Javed Butler, and Petrina Stevens. Copies of the consent forms are available for review by the Editor of this journal.
: JB has consulted for Abbott, Adrenomed AG, Amgen, Array BioPharma, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CVRx, G3 Pharmaceuticals, Impulse Dynamics, Innolife, Janssen, LivaNova, Luitpold Pharmaceuticals, Medtronic, Merck, Novartis, Novo Nordisk, Roche, and Vifor. TB is a volunteer patient advocate with the HeartLife Foundation and, as a patient with lived experience, has provided consultation on an AstraZeneca-sponsored heart failure patient engagement program. MB is a co-founder of the HeartLife Foundation and, as a patient with lived experience, has provided consultation to Boehringer Ingelheim and AstraZeneca. JC is a co-founder of the HeartLife Foundation and, as a patient with lived experience, has participated in advisory boards for Boehringer Ingelheim and AstraZeneca. TL is a patient with lived experience and has nothing to disclose. MCP has received research funding from Boehringer Ingelheim, Roche, SQ Innovations, AstraZeneca, Novartis, Novo Nordisk, Medtronic, Boston Scientific, Pharmacosmos, and 3R LifeScience; served in consultancy roles and on clinical trial committees for Boehringer Ingelheim, Novartis, Roche, Corvia Medical, AstraZeneca, Novo Nordisk, Medtronic, AbbVie, Bayer, Takeda, Cardiorentis, Pharmacosmos, and Siemens; and is supported by the British Heart Foundation (BHF) Centre of Research Excellence Award (RE/13/5/30177 and RE/18/6/34217+). CSL is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Bayer and Roche Diagnostics; has served as consultant or on the Advisory Board/Steering Committee/Executive Committee for Abbott, Actelion, Allysta Pharma, Amgen, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Darma Inc., EchoNous Inc, Impulse Dynamics, Ionis Pharmaceutical, Janssen Research & Development LLC, Medscape/WebMD Global LLC, Merck, Novartis, Novo Nordisk, Prosciento Inc, Radcliffe Group Ltd., Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics, and Us2.ai; and serves as co-founder and non-Executive Director of Us2.ai. EM and PS are employees of AstraZeneca, and PM and JV were employees of AstraZeneca at the time the study was conducted.